TY  - JOUR
AU  - Llibre, Josep M
AU  - López Cortés, Luis Fernando
AU  - Aylott, Alicia
AU  - Wynne, Brian
AU  - Matthews, Jessica
AU  - Van Solingen-Ristea, Rodica
AU  - Vandermeulen, Kati
AU  - van Wyk, Jean
AU  - Kahl, Lesley P
PY  - 2022
DO  - 10.1097/QAI.0000000000003019
UR  - http://hdl.handle.net/10668/19866
T2  - Journal of acquired immune deficiency syndromes (1999)
AB  - Switching to the 2-drug regimen dolutegravir + rilpivirine demonstrated noninferiority vs continuing a 3-drug or 4-drug current antiretroviral regimen (CAR) at week 48 and maintained high levels of virologic suppression to week 148 in the SWORD...
LA  - en
KW  - Adult
KW  - Anti-HIV Agents
KW  - Anti-Retroviral Agents
KW  - Atherosclerosis
KW  - Fatty Acid-Binding Proteins
KW  - HIV Infections
KW  - Heterocyclic Compounds, 3-Ring
KW  - Humans
KW  - Inflammation
KW  - Lipopolysaccharide Receptors
KW  - Oxazines
KW  - Piperazines
KW  - Pyridones
KW  - Rilpivirine
KW  - Viral Load
TI  - Brief Report: Evaluation of Inflammation and Atherogenesis Biomarkers Through 148 Weeks Postswitch to Dolutegravir and Rilpivirine in SWORD-1/SWORD-2.
TY  - research article
VL  - 91
ER  -